Search All News
Two drugs commonly used to treat high blood pressure are equally effective as single-drug therapies, but one is slightly safer, a new study has found.
Most of the heart and immunologic problems seen in children with multisystem inflammatory syndrome (MIS-C)—a condition linked to COVID—were gone within a few months, Columbia researchers have found.
A new study describes multiple ways to achieve the same health benefits from exercise—as long as your exercise “cocktail” includes plenty of light physical activity.
Brief pulses of ultrasound delivered to nerves near the kidney lowered blood pressure in people with drug-resistant hypertension, Columbia and NewYork-Presbyterian physicians have found.
- September 28, 2016
Columbia researchers are enrolling women in a new study to learn if inadequate sleep increases risk of heart disease.
- September 22, 2016
A study revealing new structural details of an intracellular channel that controls muscle contraction may lead to new drugs for heart and muscle diseases.
- August 24, 2016
A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy.
- June 6, 2016
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
- May 26, 2016
Wearing a 24-hour monitoring device may help identify African-Americans who have masked hypertension.
- May 25, 2016
A large study found a positive correlation between traffic-related air pollution and the amount of calcium deposited in the coronary arteries.
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
- May 15, 2016
Lowering blood pressure goals for people with cardiovascular risk factors could save tens of thousands of lives annually and reduce costs.
- April 2, 2016
Transcatheter aortic valve replacement (TAVR) is a viable alternative to open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery.